# Valar Labs

> Computational histology AI predicting cancer therapy response from pathology slides.

## Why it is interesting

CHAI tests like Vesta for bladder cancer turn standard H&E slides into treatment-selection signals — precision oncology without new assays.

## Profile

- **Stage:** series-a
- **Status:** private
- **Industries:** generalist-tech
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Series A (May 2024): $22M co-led by a16z Bio+Health and DCVC; Pear VC participated (Business Wire)
- Seed (2022): $4M led by a16z (a16z announcement)

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz
- https://venturecapitaltracker.com/fund/pear-vc

## Related articles

- https://venturecapitaltracker.com/2026-a16z-hot-portfolio-companies

---
Source: https://venturecapitaltracker.com/startup/valar-labs